1Ipragliflozin: a new drug for the treatment of type 2 diabetes mellitusL(U) Xin-ze, SUN Bo, YANG Wei, YU Fei, FU Sheng241-2442A management model of drug R&D projectXI Yan-bin, GU Xiao-hong, TANG Shi-huan, WU Tao, XIONG Wei245-2493Impact of governance structure in listed pharmaceutical companies on technological innovationCHEN Yu-ying, CHU Shu-zhen250-2544A cost analysis for two types of adjuvant anti-cancer therapy using an econometric modelGUAN Hai-jing, LIU Guo-en, WU Qiong, XIE Ji-pan, DU Xiao-yan, REN Xiao-xiao255-2595Quality control and evaluation of polysaccharide compositions in Chinese herbal medicinesZHANG Yong-wen260-263,2806Calibration of reference substances for melting pointLIU Yi, WU Jian-min, YAN Jing, WU Wei-bin, LIN Lan264-265,2707Research progress of fusion protein drugsLI Lei, XU Bing-jie, XUAN Yao-xian266-2708Construction of multiple copy secrete expression cassette for expression of hepatitis E virus ORF2128-660 in Pichia pastorisGUO Min, LEI Qing, LIU Xiao, JIANG Lin271-275,3029Advantages of traditional Chinese medicine in treating myocardial no-reflow after acute myocardial infarction/reperfusionZHANG Jin-yan, LI Shao-chun, LI Yi-kui, ZHAO Le, WENG Wei-liang, LI Lian-da276-28010Progress in small-molecule targeted therapy for the treatment of melanomaSHEN Fu-wen, YE Li, LIU Jing-ge, ZHU Yong-liang, TAO Min, QIAN Xiang-ping281-28711Progress in research of isavuconazole, a new antifungal agentSONG Ting-ting, FENG Jing-jie, MA Rong288-29712Research progress of BTK-targeting cancer chemotherapyLI Na, SUN Zhi-jian, WEI Min, LUO L(u)-song, WANG Lai298-30213Research progress in a new natural plant antibiotics-oregano oilHAN Fei, LI Jin, PAN Qiao-qiao, XU Han-lin, YANG Ming, ZHAO Zhi-dong303-30714Effect of pre-operative parecoxib sodium on the dosage of fentanyl used after radical resection of rectal carcinomaHE Xu-xiu308-31115Pharmacokinetics of bendamustine hydrochloride in cancer patients312-31616Dissolution apparatus and quality consistency evaluation for genericsGAO Yu-cheng, WANG Zhuo, YU Miao, TIAN Yu-jun, GUO Feng317-319,32417Validation of an assessment tool for evaluating the implementation of WHO GMP standards by Chinese pharmaceutical manufacturers of oral solid dosage form preparationsHUANG Bao-bin, SUN Xin-sheng, XU Ming-zhe, BAI Dong-ting, WU Zhi-ang, WU Chun-fu320-32418Synthesis, physicochemical properties and bioconversion of the mono substituted benzoate prodrugs of liguzinediol325-33019Preparation and application of tanshinone ⅡA/zein nanofibrous membraneLI Xin, ZHANG Wei, ZHANG Cai-yun, CHEN Fang-fang, LU Chuan-hua331-336,34320An experimental model of rat reflux gastritis based on metabolomicsYU Ting, BAO Yong-rui, MENG Xian-sheng, WANG Shuai337-343 